Back
Nektar Therapeutics Vs. Bel Fuse Industry Stock Comparison
Sell
38
NKTR
Nektar Therapeutics
Last Price:
1.30
Seasonality Move:
7.5%
Buy
76
BELFB
Bel Fuse
Last Price:
79.92
Seasonality Move:
13.94%
Sell
38
Nektar Therapeutics (NKTR)
is a Sell
Is Nektar Therapeutics a Buy, Sell or Hold?
- The current Nektar Therapeutics [NKTR] share price is $1.26. The Score for NKTR is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
- NKTR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
76
Bel Fuse (BELFB)
is a Buy
Is Bel Fuse a Buy, Sell or Hold?
- The current Bel Fuse [BELFB] share price is $81.03. The Score for BELFB is 76, which is 52% above its historic median score of 50, and infers lower risk than normal.
- BELFB is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
NKTR Stock Price Chart
What is Nektar Therapeutics's stock price today?
-
The Nektar Therapeutics share price today is $1.26
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NKTR is experiencing selling pressure, which indicates risk of future bearish movement.
NKTR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0 | Buy |
| Relative Strength Index (14 RSI): | 50.72 | Buy |
| Chaikin Money Flow: | -320857 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.19 - 1.31) | Buy |
| Bollinger Bands (100): | (1.16 - 1.54) | Sell |
BELFB Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.86 | Buy |
| Relative Strength Index (14 RSI): | 77.85 | Buy |
| Chaikin Money Flow: | 207452 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (63.15 - 69.97) | Buy |
| Bollinger Bands (100): | (62.12 - 69.5) | Buy |
NKTR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.27 | Sell |
| 20-day SMA: | 1.25 | Buy |
| 50-day SMA: | 1.28 | Sell |
| 200-day SMA: | 1.07 | Buy |
| 8-day EMA: | 1.26 | Sell |
| 20-day EMA: | 1.25 | Buy |
| 50-day EMA: | 1.26 | Sell |
| 200-day EMA: | 1.19 | Buy |
BELFB Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 69.56 | Buy |
| 20-day SMA: | 66.99 | Buy |
| 50-day SMA: | 67.04 | Buy |
| 200-day SMA: | 63.64 | Buy |
| 8-day EMA: | 70.81 | Buy |
| 20-day EMA: | 68.04 | Buy |
| 50-day EMA: | 66.68 | Buy |
| 200-day EMA: | 62.24 | Buy |
Nektar Therapeutics Earnings Growth & NKTR Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.61 per share, and a decrease next year of $0.06 per share.
Bel Fuse Earnings Growth & BELFB Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.53 per share, an increase next quarter of $0.66 per share, a decrease this year of $1.89 per share, and an increase next year of $0.28 per share.
Nektar Therapeutics Technical Analysis
| Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Bel Fuse Technical Analysis
| Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||